Control of volume status is a pivotal issue in haemodialysis therapy. Objective and practical management for maintaining normovolemia is needed. The investigators hypothesized that intervention of volume status with the body composition monitor (BCM) may improved hemodynamic parameters and biomarkers in hemodialysis patients.
The investigators will assess BCM in enrolled hemodialysis patients by 4 weeks for 16 weeks During the former 8-week intervention period, The investigators will adjust patients' volume status according to the results of BCM. During the latter 8-week observational period, The investigators will evaluate the changes of patients' hemodynamic parameters and biomarkers.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
160
During the interventional period, dry weight of patients will be adjusted according to the results of body composition.
Sejoong Kim
Incheon, South Korea
RECRUITINGblood pressure
Systolic blood pressure, number of anti-hypertensive agents hypotensive episode
Time frame: up to 16 weeks
biomarkers
C-reactive protein, interleukin-6, MMP-1, leptin, resistin, adiponectin, VEGF
Time frame: up to 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.